Global Emergency Contraception Market Forecast To Achieve $2.16 Billion By 2030 At 6.9% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Emergency Contraception Market Expected To Scale Between 2026 And 2030?
The emergency contraception market has demonstrated robust growth in recent years. The market is anticipated to expand from $1.55 billion in 2025 to $1.66 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.7%. This historical growth can be ascribed to several factors, including heightened awareness of emergency contraception, an increase in contraceptive failure rates, the expansion of retail pharmacy networks, growing demand for hormonal contraceptives, and regulatory approvals for emergency contraceptive pills.
The emergency contraception market is projected to experience substantial growth over the next few years. It is expected to expand to $2.16 billion by 2030, achieving a compound annual growth rate (CAGR) of 6.9%. This anticipated growth is driven by factors such as the increasing use of online pharmacy platforms, rising demand for homecare delivery, the expansion of awareness programs tailored to specific age groups, a growing preference for non-hormonal and herbal options, and the introduction of high-dose and multi-formulation products. Significant trends during this forecast period include the enhanced availability of over-the-counter emergency contraceptives, the escalating adoption of online pharmacies and home delivery services, a heightened focus on awareness initiatives for adolescents and adults, the broadening of high-dose and multi-formulation choices, and the increasing incorporation of copper intrauterine devices and non-hormonal methods.
Access Your Free Sample Report For In-Depth Market Analysis:
What Significant Factors Are Influencing The Emergency Contraception Market Expansion?
The increasing prevalence of unprotected intercourse is anticipated to propel the growth of the emergency contraception market in the future. Unprotected intercourse defines sexual activity conducted without employing any form of barrier contraception, such as condoms, or other dependable birth control methods, consequently exposing participants to the danger of unintended pregnancy and sexually transmitted infections. This rise in unprotected intercourse stems from reduced condom usage and inconsistent adoption of alternative contraceptive methods among sexually active individuals, notably young adults and adolescents, which heightens the probability of unprotected sexual encounters. Emergency contraception presents a crucial safety measure following unprotected intercourse by preventing unintended pregnancies, directly addressing the outcomes of missed or absent contraception and diminishing the immediate risk associated with unprotected sexual activity. For instance, according to the 2023 National Youth Risk Behavior Survey conducted by the Centers for Disease Control and Prevention, a US-based government agency, a 2023 survey of U.S. high school students revealed that 32% reported engaging in sexual intercourse at least once, and 48% stated they did not use a condom during their most recent sexual encounter. Therefore, the escalating rates of unprotected intercourse are driving the growth of the emergency contraception market.
How Is Segmentation Applied In The Emergency Contraception Market Segment Analysis?
The emergency contraception market covered in this report is segmented –
1) By Product Type: Levonorgestrel, Ulipristal Acetate, Mifepristone, Other Product Types
2) By Dosage Form: Tablets, Injections, Other Dosage Forms
3) By Age Group: Adolescents, Adults
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
5) By End-User: Hospitals, Clinics, Homecare, Other End Users
Subsegments:
1) By Levonorgestrel: Single Dose Tablets, Two Dose Tablets, Over The Counter Formulations, Prescription Based Formulations
2) By Ulipristal Acetate: Single Dose Tablets, Prescription Based Tablets, High Dose Formulations, Low Dose Formulations
3) By Mifepristone: Low Dose Emergency Use, Combination Regimen Formulations, Prescription Based Tablets, Clinical Setting Formulations
4) By Other Product Types: Copper Intrauterine Devices, Combined Hormonal Regimens, Non Hormonal Methods, Herbal Based Formulations
What Trends Are Shaping The Future Of The Emergency Contraception Market?
Leading companies in the emergency contraception market are concentrating on developing innovative products, such as over-the-counter emergency contraceptives, to enhance accessibility and offer swift, effective pregnancy prevention. These non-prescription emergency contraceptives are oral pills containing hormones like levonorgestrel, available without a prescription, and function to prevent pregnancy by delaying ovulation or fertilization when taken shortly after unprotected intercourse. For instance, in August 2024, Verséa Health Inc., a US-based healthcare company specializing in diagnostics and consumer health solutions, launched empowered choice, a U.S. Food and Drug Administration–approved over-the-counter emergency contraceptive intended to broaden accessible options across mainstream retail and online platforms. The introduction included nationwide distribution collaborations with major pharmacies and e-commerce channels, complemented by a comprehensive educational initiative to raise awareness regarding emergency contraception choices, correct usage, and optimal timing for effectiveness. This effort aimed to reach a wider audience, reduce the stigma surrounding emergency contraception, and ensure individuals could obtain the product quickly and discreetly. The product features a simple oral levonorgestrel formulation, assuring effective emergency pregnancy prevention, can be used without a prescription, and offers individuals greater autonomy and flexibility in their reproductive health decision-making.
Who Are The Companies Participating In The Emergency Contraception Market Environment?
Major companies operating in the emergency contraception market are Pfizer Inc.; Bayer Aktiengesellschaft, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Cipla Limited, Amneal Pharmaceuticals Inc., Lupin Limited, Gedeon Richter Plc, Zydus Lifesciences Limited, Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Mankind Pharma Limited, Piramal Pharma Limited, CooperSurgical Inc., HLL Lifecare Limited, Zhejiang Xianju Pharmaceutical Co. Ltd., AdvaCare Pharma, Afaxys Inc., Syzygy Healthcare Solutions, Foundation Consumer Healthcare, Shanghai Dahua Pharmaceutical Co. Ltd.
Get The Full Emergency Contraception Market Report:
https://www.thebusinessresearchcompany.com/report/emergency-contraception-market-report
Which Region Accounts For The Largest Portion Of The Emergency Contraception Market?
North America was the largest region in the emergency contraception market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the emergency contraception market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Emergency Contraception Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Emergency Contraception Market 2026, By The Business Research Company
adeno-associated virus (avv) vectors in gene therapy market report 2026
gastric cancer therapy market report 2026
https://www.thebusinessresearchcompany.com/report/gastric-cancer-therapy-global-market-report
over the counter (otc) drugs market report 2026
https://www.thebusinessresearchcompany.com/report/over-the-counter-otc-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
